UnannouncedVCInvestor

Bay City Capital GF Xinde International Life Sciences USD

Startup rounds since 2015 with a Bay City Capital GF Xinde International Life Sciences USD investor on the board, and the firm's own fund filings.

Raises
5
since 2015
Unannounced
0
no announcement found, of those filed since 2025
Funds
1
fund filings under the firm's name

Rounds

  1. Synchronicity Pharma, Inc.$1.6MFiled before 202525 Jan 2022 · San Jose, CA
  2. Synchronicity Pharma, Inc.$5.95MFiled before 202524 Oct 2019 · San Jose, CA
  3. ReSet Therapeutics, Inc.$1.5MFiled before 202520 Jun 2018 · San Jose, CA
  4. ReSet Therapeutics, Inc.$29.7MFiled before 202519 Feb 2016 · South San Francisco, CA
  5. Reset Therapeutics, Inc.$9.1MFiled before 20257 Oct 2015 · South San Francisco, CA

By year

YearRaisesUnannounced
20221None yet
20191None yet
20181None yet
20161None yet
20151None yet

Raises are checked for an announcement from 2025 on.

Funds

The firm's own fund filings, newest first, each at its latest filing.

FundFiledSizeRaised
Bay City Capital GF Xinde International Life Sciences USD Fund, L.P.2 Nov 2016$200MNone

Listed because a Bay City Capital GF Xinde International Life Sciences USD fund's filing names a director of each company. A name match is not a verified identity.